Selection of rAAV Vectors that Cross the Human Blood-Brain Barrier and Target the Central Nervous System Using a Transwell Model
Mark A. Kay(Io Therapeutics (United States))
Cited by 1
Related Papers
Genome engineering with Cas9 and AAV repair templates generates frequent concatemeric insertions of viral vectors
|Nature Biotechnology|2024|56
Using a barcoded AAV capsid library to select for novel clinically relevant gene therapy vectors
|bioRxiv (Cold Spring Harbor Laboratory)|2019|0